Literature DB >> 16998884

High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): phylogenetic and epidemiological analyses.

Nieves Fernández-Arcás1, Juan López-Siles, Sofia Trapero, Angelo Ferraro, Agueda Ibáñez, Francisco Orihuela, Jorge Maldonado, Antonio Alonso.   

Abstract

Hepatitis C virus (HCV) is a major aetiological agent of chronic hepatitis and it may lead to the development of liver cirrhosis and hepatocellular carcinoma. HCV has been classified into six clades as a result of high genetic variability. A commercial procedure to genotype HCV in 678 patients from Carlos Haya Regional University Hospital, Malaga was used to study the distribution of HCV genotypes in Malaga, southern Spain. A high prevalence of HCV-4 (10.2%) was found. This genotype is found more commonly in Egypt, Central Africa and the Middle East. The distribution of the different subtypes in the 69 patients with HCV-4 was as follows: 4.3% subtype 4e, 7.2% subtype 4a, 11.5% not subtypable, and 76.8% subtype 4c/4d. Of the 53 4c/4d patients, 69% were intravenous drug users and 31% non-intravenous drug users. In order to characterise further the HCV-4c/4d patients, sequences of the non-structural 5B gene (393 bp) were obtained from 36 HCV-4c/4d-infected untreated patients. Phylogenetic tree topologies distinguished clearly the two subtypes: 11 patients were infected by subtype 4c and 25 by 4d. This phylogenetic analysis, reinforced by the epidemiological characteristics, suggests the extension of the HCV-4c and -4d subtypes in the area of Malaga among both intravenous drug users and non-intravenous drug users.

Entities:  

Mesh:

Year:  2006        PMID: 16998884     DOI: 10.1002/jmv.20706

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Treatment of genotype 4 hepatitis C recurring after liver transplantation using a combination of pegylated interferon alfa-2a and ribavirin.

Authors:  Waleed Al-Hamoudi; Hazem Mohamed; Faisal Abaalkhail; Yaser Kamel; Nasser Al-Masri; Naglaa Allam; Saleh Alqahtani; Mohammed Al-Sofayan; Hatem Khalaf; Mohammed Al-Sebayel; Ahmed Al-Jedai; Ayman Abdo
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

2.  Complete genomic sequences for hepatitis C virus subtypes 4b, 4c, 4d, 4g, 4k, 4l, 4m, 4n, 4o, 4p, 4q, 4r and 4t.

Authors:  Chunhua Li; Ling Lu; Xianghong Wu; Chuanxi Wang; Phil Bennett; Teng Lu; Donald Murphy
Journal:  J Gen Virol       Date:  2009-04-08       Impact factor: 3.891

Review 3.  Epidemiology and natural history of HCV infection.

Authors:  Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

4.  European vs. Egyptian HCV-4 patients with elevated baseline HCV RNA, treated with PEG-IFN-α2a and ribavirin: the role of rapid and early virologic response.

Authors:  Dimitrios Dimitroulopoulos; Ioannis Elefsiniotis; Christos Pavlidis; Dimitrios Xinopoulos; Klisthenis Tsamakidis; Stamatina Patsavela; Dimitrios Kypreos; Ageliki Ferderigou; Dimitrios Korkolis; Sotirios Koutsounas; Georgios Saroglou; Emmanouil Paraskevas
Journal:  Hepat Mon       Date:  2010-09-01       Impact factor: 0.660

5.  Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts.

Authors:  Victoria L Demetriou; Leondios G Kostrikis
Journal:  BMC Res Notes       Date:  2011-10-31

6.  Virological surveillance, molecular phylogeny, and evolutionary dynamics of hepatitis C virus subtypes 1a and 4a isolates in patients from Saudi Arabia.

Authors:  Waleed H AlMalki; Imran Shahid; Ashraf N Abdalla; Ayman K Johargy; Muhammad Ahmed; Sajida Hassan
Journal:  Saudi J Biol Sci       Date:  2020-12-08       Impact factor: 4.219

Review 7.  Epidemiological features and specificities of HCV infection: a hospital-based cohort study in a university medical center of Calabria region.

Authors:  M C Liberto; N Marascio; E Zicca; G Matera
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090

8.  Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.

Authors:  Hamad I Al Ashgar; Mohammed Q Khan; Mohammed Al-Ahdal; Sahar Al Thawadi; Ahmad Salem Helmy; Ahmed Al Qahtani; Faisal M Sanai
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

Review 9.  Management of hepatitis c genotype 4 in the liver transplant setting.

Authors:  Waleed K Al-Hamoudi
Journal:  Saudi J Gastroenterol       Date:  2016 May-Jun       Impact factor: 2.485

10.  Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users.

Authors:  Simona Paraschiv; Leontina Banica; Ionelia Nicolae; Iulia Niculescu; Adrian Abagiu; Raluca Jipa; Andrea-Clemencia Pineda-Peña; Marta Pingarilho; Emil Neaga; Kristof Theys; Pieter Libin; Dan Otelea; Ana Abecasis
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.